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Regulation of the Inflammatory Synovial Fibroblast Phenotype by MALAT 1 LncRNA 
in Obese Patients with Osteoarthritis 
Summary: 
Inflammation and enlargement of the synovium (synovitis) is a central pathological feature of 
osteoarthritis (OA). Nanus et al find synovitis is greater in hip OA patients who are obese, 
where the synovial fibroblast cells (SF) exhibit an inflammatory phenotype with increased 
production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and C-X-C Motif 
Chemokine Ligand 8 (CXCL8), compared to either normal weight OA individuals or non-
disease controls.  
The inflammatory synovial fibroblast phenotype is associated with the expression of specific 
long non-coding RNAs (lncRNAs), a new class of gene regulators. The lncRNA MALAT1 is 
rapidly produced in OA 




Inhibition of MALAT1 
reduces the rate of SF 
cell growth and 
decreases the 




that obese hip OA 
patients have an 
inflammatory synovial 
fibroblast phenotype 
and that MALAT1 
lncRNA is a central 
regulator in mediating synovitis in OA patients who are obese.   
Key Points: 
‐ Synovial fibroblasts from obese OA patients have an inflammatory phenotype  
‐ The inflammation-associated lncRNA MALAT1 is highly abundant in obese OA 
synovial fibroblasts and is rapidly produced  in response to inflammatory cytokine 
stimulation  
‐ Inhibition of MALAT1 reduces the synovial fibroblast inflammatory phenotype by 
inhibiting the production of inflammatory cytokines 
‐ Targeted inhibition of MALAT1 could be a therapeutic approach to reducing synovitis 
in obese OA patients 
 
 
 
